TOTTORI UNIVERSITY HOSPITAL

Women's Medicine

• Head of department
  Tasuku Harada

We support the life of women, which is beautiful and dynamic.

In the Women's Medicine Division, we provide treatment for the perinatal period and reproductive endocrinological conditions. Our hospital is certified as a general perinatal mother-child medical center, accepting emergency severe high-risk pregnant women 24 hours a day. In the field of reproduction endocrinology, we provide advanced treatment such as external fertilization/embryo transfer and microinsemination and vigorously perform anticoagulant therapy for cases of habitual abortion and laparoscopic surgery for benign gynecological diseases.

Field of expertise

Endometriosis, which is considered as one of the modern diseases, is an important theme of our division. We are trying to provide the most appropriate treatment by combining surgical treatment and pharmacotherapy based on basic examination. We have multiple certified endoscopy specialists, performing less invasive laparoscopic surgery. They have also started robotic surgery, conducting clinical studies to assess its efficacy and safety.

Diseases of interests

• High-risk pregnancy
• Endometriosis, uterine fibroid
• Atocia
• Recurrent fetal loss, recurrent pregnancy loss

Principal treatment

• Therapy of fetus in utero
• Anticoagulant therapy for recurrent fetal loss patients (continuous infusion of low-molecular-weight heparin)
• External fertilization, microinsemination, blastocyst transfer, freeze preservation of fertilized ovum and sperm
• Laparoscopic surgery (hysterectomy, leiomyomectomy, resection of the focus of endometriosis, etc.)
• Robot-assisted surgery (hysterectomy, leiomyomectomy)

Principal tests

• Antenatal diagnosis (echography, MRI, villus harvest, amniotic test, etc.)
• Pelvic MRI, abdominal and pelvic CT
• Laparoscopy, hysteroscopy
• Sterilitas test (blood exam: endocrine exam, hysterosalpingography, echography: follicle monitoring, semen exam (microscopic test), etc.)

Gynecology Oncology

• Head of department
  Tasuku Harada
• Head of division
  Horoaki Itamochi

We provide multidisciplinary therapy combining surgical therapy, chemotherapy, and radiotherapy, which is of the top level in Japan. We participate in many domestic/international collaborative clinical studies, trying to provide as many therapeutic options as possible for our patients. We try to provide chemotherapy without hospitalization to the extent possible, so that the patients can lead a comfortable daily life, taking care of post-operative lymphatic edema of the lower extremities. This year, we introduce minimally invasive surgery for malignant tumors (robotic surgery and laparoscopic surgery).

Field of expertise

In addition to curative surgical therapy, we provide chemotherapy as part of international collaborative clinical studies aiming for better anti-tumor efficacy and curative radiotherapy in collaboration with the Division of Radiation Oncology.
In addition to care for the side effects related to chemotherapy and comprehensive physical therapy for post-operative lymphatic edema of the lower extremities, we try to make the daily life of patients more comfortable by introducing minimally invasive surgical therapy.

Diseases of interests

Endocervical cancer,uterine body cancer,ovarian cancer,vulval cancer,vaginal cancer,uterine sarcoma,trophoblastic disease

Principal treatment

1. Operative therapy
   Highly curable operative therapy based on care guidelines
   Diffuse uterine cervix hysterectomy: Fertility preservation operation to the stages IA2 and (part of) IB of endocervical cancer
   Laparoscopic uterus malignancy operation: The operation will be planned to be insured after meeting the facility criteria, etc. to the stage IA of uterine body cancer
   Robot-assisted laparoscopic operation: The operation is planned to be offered as a clinical study on early uterocervical malignant tumor.
2. Chemotherapy
   Chemotherapy based on care guidelines
   Chemotherapy with molecular-targeted drug (clinical study)
3. Radiotherapy
   Radical radiotherapy based on care guidelines
   Radiotherapy intended for symptom relief
4. Endocrine therapy
   Luteal hormone therapy
   Atypical endometrial hyperplasia with a request for fertility preservation, therapeutic option for part of uterine body cancer

Principal tests

Transvaginal and transabdominal echography, colposcopy, hysteroscopy, endometrial tissue hysteroscopy, HPV test, pelvic MRI test, CT test, PET-CT test